Damon Runyon: Fellowship & Career Awards

The Damon Runyon Cancer Research Foundation is a US nonprofit that funds early-career cancer researchers directly, outside the federal grant system, through a portfolio of named fellowship and career-transition awards. Founded in 1946, it has historically emphasized fast, low-bureaucracy review cycles and unrestricted, discovery-driven funding for scientists at specific career transition points — postdoctoral, physician-scientist, and early-independent-investigator — rather than funding investigator-initiated R01-style projects across all career stages the way the National Cancer Institute does. This guide covers each active award program, its funding structure and eligibility, and how the portfolio compares to federal training and career-development mechanisms, for research administrators advising applicants or hosting awardees at their institution.

For the broader landscape of nonprofit, federal, and disease-specific cancer funding, see CASRAI’s Cancer Research Funding: A Landscape Overview, which places Damon Runyon alongside the American Cancer Society, NCI, and disease-specific charities. This guide goes one level deeper into a single funder’s actual program mechanics, in the same pattern as CASRAI’s guides to the Burroughs Wellcome Fund and the Gordon and Betty Moore Foundation.

Damon Runyon’s award programs at a glance

Program	Career stage	Approximate funding	Duration
Fellowship Award	Postdoctoral (basic science and physician-scientists)	$70,000–$76,000/yr stipend plus expense allowance; up to $100,000 loan repayment for physician-scientists	Up to 4 years
St. Jude Pediatric Cancer Research Fellowship Award	Postdoctoral, pediatric-cancer focus	Structured on the Fellowship Award model, co-administered with St. Jude Children’s Research Hospital	Up to 4 years
Quantitative Biology Fellowship Award	Postdoctoral, quantitative/computational scientists entering cancer biology	Structured on the Fellowship Award model	Up to 4 years
Damon Runyon–Rachleff Innovation Award	Early-career independent investigator	$400,000 initial (2 years), extendable to $800,000 over 4 years	2 years, extendable to 4
Clinical Investigator Award	Early-career physician-scientist, patient-oriented research	$600,000 (~$200,000/yr to the institution)	3 years
Physician-Scientist Training Award	Physicians pursuing protected research training	$100,000 in year one, increasing $10,000/yr; up to $100,000 medical-school debt retirement	Up to 4 years
Dale F. Frey Award for Breakthrough Scientists	Current/former Fellows and Quantitative Biology Fellows only	Supplemental recognition funding for Fellows judged to have exceeded expectations	Varies
SPARK Program	Undergraduates and recent graduates	Structured summer/early-career research education program	Program-specific

Amounts and structures above reflect the Foundation’s published guidelines as of 2026 and can change year to year — always confirm current figures against the Foundation’s own award-programs page before advising an applicant or budgeting an award.

Fellowship Award

The Fellowship Award is Damon Runyon’s flagship postdoctoral mechanism, funding early-career scientists — both PhD-track basic researchers and physician-scientists — to train in a sponsor’s laboratory. Eligibility runs on two tracks. Basic-science and Level 1 physician-scientist applicants must generally be within about 18 months of receiving their degree and have spent no more than roughly one year in the sponsoring lab at the time of application. Level 2 (physician-scientist) applicants must have completed residency and clinical training, be board-eligible in the United States, and commit at least 80% of their time to the funded research. Foreign nationals are eligible but must conduct the funded research within the United States. Awards provide an annual stipend in the $70,000–$76,000 range plus a research/expense allowance, with physician-scientist tracks eligible for medical-school loan repayment up to $100,000 and a per-dependent-child allowance, over a term of up to four years.

St. Jude Pediatric Cancer Research Fellowship Award

Co-administered with St. Jude Children’s Research Hospital, this track applies the Fellowship Award’s structure and eligibility model specifically to postdoctoral scientists whose research addresses pediatric-cancer prevention, diagnosis, or treatment. Institutions hosting a pediatric-oncology postdoctoral trainee should treat it as a parallel entry point to the general Fellowship Award rather than a separate funding stream with different terms.

Quantitative Biology Fellowship Award

This track is aimed at postdoctoral scientists with primary training in mathematics, computer science, physics, statistics, or engineering who are moving into computational or quantitative cancer-biology research. It exists because standard biomedical fellowship review panels do not always evaluate quantitative-methods training and preliminary work on the same terms as bench-science preliminary data; Damon Runyon reviews these applications through a track calibrated to that background. Funding structure mirrors the standard Fellowship Award.

Damon Runyon–Rachleff Innovation Award

The Rachleff Innovation Award targets early-career independent investigators with high-risk, high-reward research ideas that lack the preliminary data typically required by federal review panels — explicitly a complement to, not a substitute for, an R01 or equivalent. Initial funding is $400,000 over two years; awardees who show sufficient progress are eligible for a second phase extending total funding to $800,000 over four years. Because it is structured around idea risk rather than credentialed preliminary data, it functions similarly in intent to the NIH Director’s New Innovator Award (DP2), though the two are administered independently and have different eligibility windows and review processes — institutions should not assume overlap in application materials.

Clinical Investigator Award

The Clinical Investigator Award funds early-career physician-scientists conducting patient-oriented cancer research that bridges laboratory and clinical practice. It provides $600,000 total, disbursed at roughly $200,000 per year over three years, paid to the awardee’s institution rather than as a personal stipend. A separate Clinical Investigator Award Continuation Grant exists for awardees seeking additional support beyond the initial term; research administrators should confirm current continuation-grant terms directly with the Foundation, since continuation eligibility and amounts are reviewed separately from the initial award.

Physician-Scientist Training Award

This award supports physicians pursuing a protected research-training period en route to an independent cancer-research career, distinct from the Clinical Investigator Award’s focus on already-established patient-oriented research programs. Funding starts at $100,000 in the first year and increases by $10,000 per year across a four-year term, with up to $100,000 of remaining medical-school debt eligible for retirement by the Foundation — a structural feature aimed specifically at physician-scientists for whom debt load is a documented barrier to choosing a research career over a purely clinical one.

Dale F. Frey Award for Breakthrough Scientists

Unlike the programs above, the Dale F. Frey Award is not a standalone application track. It recognizes current or former Damon Runyon Fellows and Quantitative Biology Fellows whose work during their fellowship term is judged by the Foundation to have exceeded expectations, providing supplemental funding on top of their existing award. Institutions should understand this as an internal recognition mechanism layered onto the Fellowship Award rather than a program applicants can apply to directly.

SPARK Program

SPARK (Scholars Program for Advancing Research and Knowledge) sits earlier in the pipeline than the Foundation’s other programs, aiming to bring talented undergraduates and recent graduates into rigorous cancer-research training as a pathway into the research workforce. It is best understood by research administrators as a pipeline/outreach program rather than a competitive research-funding mechanism in the same sense as the Fellowship or Clinical Investigator Awards.

How Damon Runyon compares to federal training and career-development mechanisms

Damon Runyon’s postdoctoral and physician-scientist tracks occupy similar career-stage territory to NIH’s F-series individual fellowships and K-series career development (K) awards, but the mechanics differ in ways that matter for institutional planning:

Speed and overhead: private foundation review cycles are typically faster and lower-overhead than NIH’s study-section process, though also more selective in absolute application volume accepted per cycle.
Indirect costs: private foundation awards, including Damon Runyon’s, generally do not carry a federally negotiated facilities-and-administrative (indirect cost) rate the way NIH awards do — sponsored-programs offices should confirm the applicable indirect-cost policy for each Damon Runyon program before budgeting, since foundation policy on this point can differ from an institution’s federal rate and can change over time.
Portability: Fellowship-track awards are generally portable to a limited set of sponsor-approved host institutions, similar in spirit to NIH F32 fellowships but governed by the Foundation’s own sponsor-approval process rather than NIH’s.
Stacking with federal support: institutions frequently see Damon Runyon awards layered alongside, rather than instead of, federal training or career-development support at the same career stage — research administrators should check each program’s specific policy on concurrent federal funding before assuming they combine freely.

Applying to Damon Runyon programs: general process notes

Each program has its own online application portal, deadline, and letter-of-support requirements published directly by the Foundation; there is no unified single deadline across programs. Common mechanics across most tracks:

Applications are typically submitted through the Foundation’s own online system rather than Grants.gov or a federal portal.
Sponsor/mentor letters of support and institutional endorsement are required for postdoctoral and training-track programs, similar in structure — though not identical in form — to the sponsor statements required for NIH F- and K-series applications.
Because deadlines and eligibility windows are program-specific and change year to year, institutions should treat the Foundation’s own application guidelines page as the current source of record rather than relying on a cached deadline from a prior cycle.
Sponsored-programs offices should route Damon Runyon applications through their standard internal proposal-routing and institutional-endorsement process even though the sponsor is not a federal agency — institutional signoff, conflict-of-interest disclosure, and compliance review requirements typically still apply.

Frequently asked questions

Is the Damon Runyon Cancer Research Foundation a federal agency?

No. It is a private, independent nonprofit foundation, unaffiliated with the National Cancer Institute or any other federal agency, though its award recipients frequently also hold or later obtain NIH/NCI funding.

Can a Damon Runyon award be combined with an NIH award for the same researcher?

Often yes, but the specifics depend on the individual program’s policy on concurrent support and on the terms of the federal award in question. Research administrators should confirm both funders’ concurrent-support and effort-commitment rules before assuming full stacking is permitted, particularly where a program specifies a minimum percentage of committed research effort.

Do Damon Runyon awards carry indirect costs (F&A)?

Policy on indirect costs varies by program and can change; sponsored-programs offices should confirm the current indirect-cost policy directly with the Foundation for the specific program and award year rather than assuming parity with federal indirect-cost treatment.

Who is eligible to apply to the Fellowship Award?

Early-career postdoctoral scientists, both PhD-track and physician-scientists, generally within about 18 months of their degree (or, for the physician-scientist track, having completed residency/clinical training and board-eligible in the US). See the Fellowship Award section above for the two eligibility levels.

What is the difference between the Clinical Investigator Award and the Physician-Scientist Training Award?

The Clinical Investigator Award funds an already-established early-career physician-scientist’s patient-oriented research program ($600,000 over three years, paid to the institution). The Physician-Scientist Training Award instead funds a protected research-training period for a physician moving toward an independent research career, with a smaller first-year amount that increases annually plus medical-school debt retirement.

Damon Runyon Cancer Research Foundation: Fellowship and Career Award Programs